Vivimed Labs informs about resignation of CFO

06 Feb 2026 Evaluate
Vivimed Labs has informed that Phaninder Nath P S, Chief Financial Officer (Key Managerial Personnel-KMP and Senior Management Personnel -SMP) of the Company, has tendered his resignation from the services of the Company w.ef. the close of business hours on February 06, 2026 due to personnel health issues. Phaninder Nath P S, Chief Financial Officer of the Company, will also cease to be KMP under Section 203 and other applicable provisions, if any, of the Companies Act, 2013 and Regulation 30(5) of the SEBI Listing Regulations with effective from the close of business hours on February 06, 2026 for determining materiality of any event or transaction for the purpose of making the required disclosures to the stock exchange(s). The details as required under Regulation 30 of the SEBI Listing Regulations read with Part A of Schedule Il thereof and SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 are enclosed as Annexure A. The resignation letter received from Phaninder Nath P S, is enclosed as Annexure B.

The above information is a part of company’s filings submitted to BSE.

Vivimed Labs Share Price

7.48 -0.03 (-0.40%)
27-Feb-2026 15:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1735.90
Dr. Reddys Lab 1285.85
Cipla 1348.50
Zydus Lifesciences 921.55
Lupin 2299.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×